ChIP-qPCR studies validated the co-enrichment of BCL9 and STAT3 on two enhancer elements associated with ITGB3. Furthermore, we showed that BCL9 transcriptional regulation of integrin β3 played a key role in DCIS invasive progression. This evidence concerns the gene ITGB3 and ductal breast carcinoma in situ.